181 related articles for article (PubMed ID: 28750274)
1. Medical treatment of advanced chordomas.
Colia V; Stacchiotti S
Eur J Cancer; 2017 Sep; 83():220-228. PubMed ID: 28750274
[TBL] [Abstract][Full Text] [Related]
2. Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.
Lebellec L; Aubert S; Zaïri F; Ryckewaert T; Chauffert B; Penel N
Crit Rev Oncol Hematol; 2015 Jul; 95(1):125-31. PubMed ID: 25682222
[TBL] [Abstract][Full Text] [Related]
3. The next step: innovative molecular targeted therapies for treatment of intracranial chordoma patients.
Barry JJ; Jian BJ; Sughrue ME; Kane AJ; Mills SA; Tihan T; Parsa AT
Neurosurgery; 2011 Jan; 68(1):231-40; discussion 240-1. PubMed ID: 21099719
[TBL] [Abstract][Full Text] [Related]
4. Chordoma: current concepts, management, and future directions.
Walcott BP; Nahed BV; Mohyeldin A; Coumans JV; Kahle KT; Ferreira MJ
Lancet Oncol; 2012 Feb; 13(2):e69-76. PubMed ID: 22300861
[TBL] [Abstract][Full Text] [Related]
5. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
Banu MA; Raza SM; Amini M; Seaman S; Rubino F; Snyder R; Patel S; DeMonte F; Conley AP
Neurosurg Focus; 2024 May; 56(5):E15. PubMed ID: 38691867
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review.
Launay SG; Chetaille B; Medina F; Perrot D; Nazarian S; Guiramand J; Moureau-Zabotto L; Bertucci F
BMC Cancer; 2011 Oct; 11():423. PubMed ID: 21970335
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary metastatic chordoma improved by platinum-based chemotherapy.
Lee MH; Kim SR; Jeong JS; Lee EJ; Lee YC
Lung Cancer; 2012 May; 76(2):255-7. PubMed ID: 22398139
[TBL] [Abstract][Full Text] [Related]
8. Novel therapeutic targets in chordoma.
Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
[TBL] [Abstract][Full Text] [Related]
9. Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies.
Bozzi F; Manenti G; Conca E; Stacchiotti S; Messina A; Dagrada G; Gronchi A; Panizza P; Pierotti MA; Tamborini E; Pilotti S
Neuro Oncol; 2014 Jan; 16(1):72-80. PubMed ID: 24366975
[TBL] [Abstract][Full Text] [Related]
10. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
11. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases.
Fleming GF; Heimann PS; Stephens JK; Simon MA; Ferguson MK; Benjamin RS; Samuels BL
Cancer; 1993 Aug; 72(3):714-8. PubMed ID: 8334623
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological therapies for Liposarcoma.
Saponara M; Stacchiotti S; Gronchi A
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):361-377. PubMed ID: 28135854
[TBL] [Abstract][Full Text] [Related]
13. Chordoma: a case series and review of the literature.
Alan O; Akin Telli T; Ercelep O; Tanrikulu Simsek E; Basoglu Tuylu T; Mutis A; Hasanov R; Kaya S; Akgül Babacan N; Dane F; Yumuk PF
J Med Case Rep; 2018 Aug; 12(1):239. PubMed ID: 30145982
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse.
Fagundes MA; Hug EB; Liebsch NJ; Daly W; Efird J; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):579-84. PubMed ID: 7558946
[TBL] [Abstract][Full Text] [Related]
15. Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
Lebellec L; Chauffert B; Blay JY; Le Cesne A; Chevreau C; Bompas E; Bertucci F; Cupissol D; Fabbro M; Saada-Bouzid E; Duffaud F; Feuvret L; Bonneville-Levard A; Bay JO; Vauleon E; Vinceneux A; Noel G; Penel N; Mir O
Eur J Cancer; 2017 Jul; 79():119-128. PubMed ID: 28478340
[TBL] [Abstract][Full Text] [Related]
16. Chordoma: the nonsarcoma primary bone tumor.
Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
[TBL] [Abstract][Full Text] [Related]
17. Chordoma.
Casali PG; Stacchiotti S; Sangalli C; Olmi P; Gronchi A
Curr Opin Oncol; 2007 Jul; 19(4):367-70. PubMed ID: 17545801
[TBL] [Abstract][Full Text] [Related]
18. The effects of chemotherapeutic agents on differentiated chordoma cells.
Bayrak OF; Aydemir E; Gulluoglu S; Sahin F; Sevli S; Yalvac ME; Acar H; Ozen M
J Neurosurg Spine; 2011 Dec; 15(6):620-4. PubMed ID: 21905773
[TBL] [Abstract][Full Text] [Related]
19. Challenges of local recurrence and cure in low grade malignant tumors of the spine.
Boriani S; Saravanja D; Yamada Y; Varga PP; Biagini R; Fisher CG
Spine (Phila Pa 1976); 2009 Oct; 34(22 Suppl):S48-57. PubMed ID: 19829277
[TBL] [Abstract][Full Text] [Related]
20. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]